CC
ACET icon

Centiva Capital’s Adicet Bio ACET Stock Holding History

Centiva Capital’s Portfolio ACET Stock Details ACET Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-6,788
Closed -$131K – 2080
2024
Q2 		$131K Buy
+6,788
New +$182K ﹤0.01% 1798
2023
Q3 		– Sell
-812
Closed -$31.6K – 1680
2023
Q2 		$31.6K Sell
812
-285
-26% -$25.2K ﹤0.01% 1527
2023
Q1 		$101K Buy
+1,097
New +$138K ﹤0.01% 1343

Other funds holding ACET

O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CG
Carlyle Group Washington, District of Columbia $10B AUM 10.61% 1-Year Est. Return
ACM
Aquilo Capital Management San Francisco, California $55.8M AUM 41.76% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Blackstone Inc
Blackstone Inc New York $32.9B AUM 23.66% 1-Year Est. Return

Centiva Capital's ACET Position: Q3 2024 in Review

Centiva Capital sold out of Adicet Bio (ACET) in Q3 2024, closing a stake of 6,788 shares — an estimated $131K sold.

Centiva Capital first reported a position in ACET in Q1 2023 and held it in 3 quarters. The position peaked at $131K in Q2 2024. 64 funds tracked by Wall St. Rank hold ACET as of Q3 2024.

  • Centiva Capital reported no remaining Adicet Bio position as of Q3 2024 after selling out during the quarter.
  • Centiva Capital sold 6,788 Adicet Bio shares in Q3 2024, an estimated $131K.
  • Centiva Capital first reported a position in Adicet Bio in Q1 2023 and held it in 3 quarters.
  • Centiva Capital's Adicet Bio position peaked at $131K in Q2 2024.
  • 64 funds tracked by Wall St. Rank held Adicet Bio as of Q3 2024.

Based on Centiva Capital's 13F filing for Q3 2024, filed 14 Nov 2024.